mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.005 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.005 |